These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 19616555

  • 1. Endocannabinoids and cannabinoid analogues block human cardiac Kv4.3 channels in a receptor-independent manner.
    Amorós I, Barana A, Caballero R, Gómez R, Osuna L, Lillo MP, Tamargo J, Delpón E.
    J Mol Cell Cardiol; 2010 Jan; 48(1):201-10. PubMed ID: 19616555
    [Abstract] [Full Text] [Related]

  • 2. Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner.
    Barana A, Amorós I, Caballero R, Gómez R, Osuna L, Lillo MP, Blázquez C, Guzmán M, Delpón E, Tamargo J.
    Cardiovasc Res; 2010 Jan 01; 85(1):56-67. PubMed ID: 19689982
    [Abstract] [Full Text] [Related]

  • 3. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
    Di Marzo V, Melck D, Orlando P, Bisogno T, Zagoory O, Bifulco M, Vogel Z, De Petrocellis L.
    Biochem J; 2001 Aug 15; 358(Pt 1):249-55. PubMed ID: 11485574
    [Abstract] [Full Text] [Related]

  • 4. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide.
    Jonsson KO, Vandevoorde S, Lambert DM, Tiger G, Fowler CJ.
    Br J Pharmacol; 2001 Aug 15; 133(8):1263-75. PubMed ID: 11498512
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The endocannabinoids anandamide and virodhamine modulate the activity of the candidate cannabinoid receptor GPR55.
    Sharir H, Console-Bram L, Mundy C, Popoff SN, Kapur A, Abood ME.
    J Neuroimmune Pharmacol; 2012 Dec 15; 7(4):856-65. PubMed ID: 22454039
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.
    Gonsiorek W, Lunn C, Fan X, Narula S, Lundell D, Hipkin RW.
    Mol Pharmacol; 2000 May 15; 57(5):1045-50. PubMed ID: 10779390
    [Abstract] [Full Text] [Related]

  • 9. Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum.
    Maccarrone M, Rossi S, Bari M, De Chiara V, Fezza F, Musella A, Gasperi V, Prosperetti C, Bernardi G, Finazzi-Agrò A, Cravatt BF, Centonze D.
    Nat Neurosci; 2008 Feb 15; 11(2):152-9. PubMed ID: 18204441
    [Abstract] [Full Text] [Related]

  • 10. Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide--targets for drug development?
    Fowler CJ, Jacobsson SO.
    Prostaglandins Leukot Essent Fatty Acids; 2002 Feb 15; 66(2-3):193-200. PubMed ID: 12052035
    [Abstract] [Full Text] [Related]

  • 11. Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy.
    Citraro R, Russo E, Scicchitano F, van Rijn CM, Cosco D, Avagliano C, Russo R, D'Agostino G, Petrosino S, Guida F, Gatta L, van Luijtelaar G, Maione S, Di Marzo V, Calignano A, De Sarro G.
    Neuropharmacology; 2013 Jun 15; 69():115-26. PubMed ID: 23206503
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The endocannabinoids anandamide and 2-arachidonoylglycerol inhibit cholinergic contractility in the human colon.
    Smid SD, Bjorklund CK, Svensson KM, Heigis S, Revesz A.
    Eur J Pharmacol; 2007 Dec 01; 575(1-3):168-76. PubMed ID: 17706636
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. CB1 cannabinoid receptor-dependent and -independent inhibition of depolarization-induced calcium influx in oligodendrocytes.
    Mato S, Alberdi E, Ledent C, Watanabe M, Matute C.
    Glia; 2009 Feb 01; 57(3):295-306. PubMed ID: 18814177
    [Abstract] [Full Text] [Related]

  • 18. Fatty acid amide hydrolase inhibition enhances the anti-allodynic actions of endocannabinoids in a model of acute pain adapted for the mouse.
    Palmer JA, Higuera ES, Chang L, Chaplan SR.
    Neuroscience; 2008 Jul 17; 154(4):1554-61. PubMed ID: 18541380
    [Abstract] [Full Text] [Related]

  • 19. 'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors.
    Ho WS, Barrett DA, Randall MD.
    Br J Pharmacol; 2008 Nov 17; 155(6):837-46. PubMed ID: 18695637
    [Abstract] [Full Text] [Related]

  • 20. Nitric oxide inhibits Kv4.3 and human cardiac transient outward potassium current (Ito1).
    Gómez R, Núñez L, Vaquero M, Amorós I, Barana A, de Prada T, Macaya C, Maroto L, Rodríguez E, Caballero R, López-Farré A, Tamargo J, Delpón E.
    Cardiovasc Res; 2008 Dec 01; 80(3):375-84. PubMed ID: 18678642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.